LeadStory

CNBC

CMS releases 2027 drug prices under Medicare negotiation program

CNBC · Current
CNBC
CNBC
Current

CNBC's Bertha Coombs joins 'Fast Money' with breaking on Medicare drug pricing.

Breakdown
  • CMS released negotiated drug prices under the Inflation Reduction Act for Medicare Part D, effective in 2027. 4s
  • Diabetes drugs including Ozempic, Wachovia, and Rebelsis will be priced at $274, 71% below list price, with a Most Favored Nation price of $245 prevailing. 9s
  • Janument by Merck for type 2 diabetes will cost $80, 85% below list price; Torgenta from Beringer Ingleham will cost $78, 84% below list price. 30s
  • Cancer drugs are among the most expensive, with Polymist for myeloma set at $86.50, a 60% discount. 36s
HealthEconomy